Hypershell takes $50M more on $120M Series B series as consumer exoskeletons step out of niche

Hypershell, a Shanghai-based consumer exoskeleton company, raised a $50m Series B+ co-led by Ant Group and Meituan Dragonball, with Sofina and Granite Asia participating. Cygnus Equity acted as exclusive financial advisor. The round is the second tranche of a Series B series, bringing total funding to $120m at a near-$400m post-money valuation. The funding cadence shows $70m raised in pre-B and B rounds within a twelve-month window, followed by the $50m B+ round. The company positions its Hypershell X series as the first consumer exoskeleton ranked first on Amazon by both sales volume and market share in the US and Europe. The product traces back to a 2023 Kickstarter that raised $1.23m from 2,638 backers, and reviewers report results consistent with claimed exertion reduction and leg effectiveness gains.

"Hypershell, the Shanghai-based consumer-exoskeleton company, has raised a $50m Series B+ co-led by Ant Group and Meituan Dragonball (referred to in the announcement as DragonBall Capital), with Sofina and Granite Asia participating. Cygnus Equity served as the exclusive financial advisor. The round is the second tranche of a Series B series that takes the company's total raised to $120m at a near-$400m post-money valuation, Yicai Global has separately confirmed."

"What gives the round its category-defining quality is the timing. The wider B series, on Hypershell's own disclosures, was raised inside a twelve-month window: $70m in pre-B and B rounds in November 2024, led by Luminous Ventures and 5Y Capital, then today's $50m Series B+. That cadence, on the cleanest read of the cap table, signals that Ant Group and Meituan Dragonball entered at the moment Hypershell's unit economics moved from product-market-fit demonstration to volume-scaling proof point."

"The company's Hypershell X series is, on the company's own framing, the first consumer exoskeleton ranked first on Amazon by both sales volume and market share in the US and Europe. The product story behind the financing is the part that has been visible since 2023, when Hypershell ran the first consumer-grade exoskeleton Kickstarter and crossed $1.23m in pledges from 2,638 backers."

"The first-generation device translated medical-and-industrial exoskeleton engineering into a sub-2kg consumer wearable aimed at hikers, travellers, athletes, and aged-mobility users. Independent reviewers, including Fast Company's gear desk, have since put the product through routine consumer scenarios with results that fit the company's claimed 30% reduction in physical exertion and ~40% increase in effective leg s"

Read at TNW | Investors-Funding